What is VRAYLAR?
Vraylar is a medication that is used in the treatment of various mental health conditions such as bipolar disorder and schizophrenia. It is classified as an atypical antipsychotic medication, meaning that it works by balancing the levels of dopamine and serotonin in the brain.
Vraylar is manufactured by Allergan and was approved by the United States Food and Drug Administration (FDA) in 2015. It is available in capsule form and is typically taken once daily with food. The dosage of Vraylar will vary depending on the specific condition being treated and the severity of the symptoms.
One of the major benefits of Vraylar is that it has been shown to be effective in treating both depressive and manic episodes associated with bipolar disorder. It has also been shown to improve the positive symptoms of schizophrenia, such as delusions and hallucinations, as well as the negative symptoms, such as lack of motivation or emotional expression.
As with all medications, Vraylar may cause side effects in some individuals. Some common side effects of Vraylar include drowsiness, dizziness, weight gain, and metabolic changes. More serious side effects may include seizures, high blood sugar, and decreased white blood cell count. If you experience any of these symptoms, it is important to consult with your doctor immediately.
Overall, Vraylar is an important medication that has helped many individuals with mental health conditions improve their symptoms and overall quality of life. If you believe that Vraylar may be a good option for you, it is important to discuss this medication with your doctor to determine if it is appropriate for your specific needs.
Frequently Asked Questions about vraylar
VRAYLAR works to help control the mood swings of bipolar I disorder in adults, providing full-spectrum relief for all bipolar I symptoms: bipolar I depression and acute manic or mixed episodes. Studies have shown VRAYLAR can: Improve overall depressive and manic symptoms*
The FDA has approved cariprazine (Vraylar; AbbVie, Gedeon Richter) as an adjunctive therapy to antidepressants for treating adult patients with major depressive disorder (MDD).
Vraylar (cariprazine) is taken by mouth once a day. Some common side effects of this medication include uncontrolled muscle movements, headache, and restlessness. Unlike other antipsychotic medications, Vraylar (cariprazine) causes minimal weight gain.
Vraylar is an antipsychotic medication, but it also has an antidepressant effect. While you take Vraylar, your doctor may monitor you closely for any signs of suicidal thoughts and behaviors.
Brand-name vs.
Vraylar is only available as a brand-name drug. It doesn't come in a generic version. A generic drug is an exact copy of the active drug in a brand-name medication. Generics tend to cost less than brand-name drugs.
Cariprazine is a medication that works in the brain to treat schizophrenia and bipolar disorder. It is also known as a second-generation antipsychotic (SGA) or atypical antipsychotic. Cariprazine rebalances dopamine and serotonin to improve thinking, mood, and behavior.
Although rare, taking Vraylar can cause a serious side effect called tardive dyskinesia. It refers to uncontrolled body movements that are repetitive. Symptoms of tardive dyskinesia can include: chewing motions.
Treatment with Vraylar is expected to cost approximately $1,789 per patient per year. CDEC recommends that cariprazine not be reimbursed for the treatment of schizophrenia in adults.
VRAYLAR may cause movements that you cannot control in your face, tongue, or other body parts. Tardive dyskinesia may not go away, even if you stop taking VRAYLAR. Tardive dyskinesia may also start after you stop taking VRAYLAR.
The most common side effects of VRAYLAR include: difficulty moving or slow movements, tremors, uncontrolled body movements, restlessness and feeling like you need to move around, sleepiness, nausea, vomiting, indigestion, constipation, feeling tired, trouble sleeping, increased appetite, and dizziness.
Vraylar is an atypical antipsychotic that is effective for the treatment of schizophrenia and bipolar disorder. Vraylar is usually well-tolerated and less likely than some other antipsychotics to cause elevations in blood sugar or total cholesterol levels, sedation, or weight gain.
Cariprazine is a medication that works in the brain to treat schizophrenia and bipolar disorder. It is also known as a second-generation antipsychotic (SGA) or atypical antipsychotic. Cariprazine rebalances dopamine and serotonin to improve thinking, mood, and behavior.
Within the first 1-2 weeks hallucinations, disorganized thinking and delusions may improve. After 1-2 weeks patients may feel more motivated and have a greater desire to be around other people.
Weight gain is a possible side effect from treatment with drugs classified as atypical antipsychotics, including Vraylar. However, weight gain wasn't common in clinical trials of Vraylar. And it was usually mild when it did occur. Your doctor will typically measure your body weight before you start taking Vraylar.
The most common side effects of VRAYLAR include: difficulty moving or slow movements, tremors, uncontrolled body movements, restlessness and feeling like you need to move around, sleepiness, nausea, vomiting, indigestion, constipation, feeling tired, trouble sleeping, increased appetite, and dizziness.
Cariprazine is a medication that works in the brain to treat schizophrenia and bipolar disorder. It is also known as a second-generation antipsychotic (SGA) or atypical antipsychotic. Cariprazine rebalances dopamine and serotonin to improve thinking, mood, and behavior.
